Leo Brokerage, LLC Cassava Sciences Inc Transaction History

Leo Brokerage, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$32.6 - $53.05 $152,405 - $248,008	-4,675 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$41.79 - $135.3 $28,208 - $91,327	675 Added 16.88%	4,675 $290,000
Q2 2021 Aug 04, 2021	BUY	$32.15 - $89.72 $128,600 - $358,880	4,000 New	4,000 $342,000

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $93.8M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Leo Brokerage, LLC, based on Form 13F filings with the SEC.

Stay updated on Leo Brokerage, LLC with notifications on news.